China strengthens drug IP regime with new trial-data protection rules
China is strengthening protections for innovative drugs through a new regime combining patent and trial-data protection, potentially delaying generic competition even after drug patents expire.China is strengthening protections for innovative drugs...To view the full article, register now.
Already a subscriber? Click here to view full article